Wu et al., 2020 - Google Patents
Fluidic multivalent membrane nanointerface enables synergetic enrichment of circulating tumor cells with high efficiency and viabilityWu et al., 2020
- Document ID
- 5683914270158616824
- Author
- Wu L
- Ding H
- Qu X
- Shi X
- Yang J
- Huang M
- Zhang J
- Zhang H
- Song J
- Zhu L
- Song Y
- Ma Y
- Yang C
- Publication year
- Publication venue
- Journal of the American Chemical Society
External Links
Snippet
The ubiquitous biomembrane interface, with its dynamic lateral fluidity, allows membrane- bound components to rearrange and localize for high-affinity multivalent ligand–receptor interactions in diverse life activities. Inspired by this, we herein engineered a fluidic …
- 208000005443 Circulating Neoplastic Cells 0 title abstract description 195
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Fluidic multivalent membrane nanointerface enables synergetic enrichment of circulating tumor cells with high efficiency and viability | |
| Li et al. | DNA framework-programmed cell capture via topology-engineered receptor–ligand interactions | |
| Park et al. | Enhanced isolation and release of circulating tumor cells using nanoparticle binding and ligand exchange in a microfluidic chip | |
| Dou et al. | Aptamer-functionalized and gold nanoparticle array-decorated magnetic graphene nanosheets enable multiplexed and sensitive electrochemical detection of rare circulating tumor cells in whole blood | |
| He et al. | Multifunctional branched nanostraw-electroporation platform for intracellular regulation and monitoring of circulating tumor cells | |
| Pan et al. | Aptamer-gated ion channel for ultrasensitive mucin 1 detection | |
| Xu et al. | Magnetic-based microfluidic device for on-chip isolation and detection of tumor-derived exosomes | |
| Ding et al. | Tannic acid (TA)-functionalized magnetic nanoparticles for EpCAM-independent circulating tumor cell (CTC) isolation from patients with different cancers | |
| Cao et al. | Ultrasensitive capture, detection, and release of circulating tumor cells using a nanochannel–ion channel hybrid coupled with electrochemical detection technique | |
| Qi et al. | Harnessing surface-functionalized metal–organic frameworks for selective tumor cell capture | |
| Yang et al. | In situ-generated multivalent aptamer network for efficient capture and sensitive electrochemical detection of circulating tumor cells in whole blood | |
| Zhai et al. | Highly efficient capture and electrochemical release of circulating tumor cells by using aptamers modified gold nanowire arrays | |
| Lv et al. | Near-infrared light-responsive hydrogel for specific recognition and photothermal site-release of circulating tumor cells | |
| Cheng et al. | Three-dimensional scaffold chip with thermosensitive coating for capture and reversible release of individual and cluster of circulating tumor cells | |
| Sheng et al. | Multivalent DNA nanospheres for enhanced capture of cancer cells in microfluidic devices | |
| Lu et al. | Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells | |
| Shah et al. | Biopolymer system for cell recovery from microfluidic cell capture devices | |
| Zhang et al. | Biomimetic microfluidic system for fast and specific detection of circulating tumor cells | |
| Wang et al. | Efficient capture of cancer cells by their replicated surfaces reveals multiscale topographic interactions coupled with molecular recognition | |
| Yin et al. | A multifunctional platform for the capture, release, and enumeration of circulating tumor cells based on aptamer binding, nicking endonuclease-assisted amplification, and inductively coupled plasma mass spectrometry detection | |
| Xie et al. | Engineered decomposable multifunctional nanobioprobes for capture and release of rare cancer cells | |
| Luan et al. | Folic acid-functionalized hybrid photonic barcodes for capture and release of circulating tumor cells | |
| Liu et al. | Artificial antibody with site-enhanced multivalent aptamers for specific capture of circulating tumor cells | |
| Peng et al. | Direct analysis of rare circulating tumor cells in whole blood based on their controlled capture and release on electrode surface | |
| Jin et al. | Multivalence-actuated DNA nanomachines enable bicolor exosomal phenotyping and PD-L1-guided therapy monitoring |